RE:RE:RE:RE:RE:RE:RE:RE:New Deal for Adstiladrin @BK: aren't you glossing over very obvious facts? For one, there is no more "short operating runway" as a justification for raising as-needed cheap cash. Hardly any outsider invested in the last round. You would know this if you were objective. Without BTD, it will get even harder. Did you notice that in the article SF sent along talking about all the bladder cancer trials out there (focus was Adstiladrin), there is NO mention of TLD-1433, despite the great CR rates and us being deep into phase 2? There are nearly a dozen others mentioned. So much for "the data being peer reviewed, scrutinized and analyzed", So, yes, the science is great but it takes more than science to execute and make the world take notice. Spare us the hero worship and " have faith" lectures. Have been hearing it for 15 years. We're investing our own money here.
Bigkahuna57 wrote: Not everyone here is invested/committed to the success of this company. Claiming objectivity in the analysis while saying management is a failure is obviously false. If you can't admit to the share price suppression and manipulation, then you're not acknowledging any form of objectivity. The question is "why suppress the share price?" Easy. Make raising greater amounts of funding during each raise less valuable." It makes the operating runway shorter between raises. The siimple solution to the negative comments and analysis is to just leave and find a more lucrative investment.
The success is clearly based on the trail and progression of the data. The trial and data determine our rate of progression to commericalization of Ruvidar. The data has been peer reviewed, scrutinized and analyzed repeatedly. No clinician or Dr. has opined negatively on the progression of the effects. Nobody.
I read wiith great interest side comments regarding TMDIF. The distinction of this particular company and management behavior is profoundly different than the "other" Canadian (Titan Medical). Theralase management has significant investment and they (collectively) hold millions of shares. TMDIF management never invested personal money. And (IMO) that investment is far from "done." I'd gather no one who is aware of Enos 1,2 or 3 has ever been to Chapel Hill, seen the robot(s) or touched them. They are real, and phenominal. Yes, I've been there.
If I read anyone trying to convince me about an investment, under the guise of "saving myself," I conclude they have a different agenda than being objective. That would include taking the "contrarian" view of this investment too. Again, I have to ask "Why are you here?"
So long as Roger and company have significant personal shares from personal funds, I'm of the opinion they won't move to the NASDAQ on thier own. They'll wait to be acquired so as to not expose themselves to excessive shorting. Which also includes the damnable reverse split. He won't be exposing his shares to that risk. IMO.
Good luck to all.
Regards, BK.